Prescient Therapeutics, Ltd.

For profitWebsite ↗

Also known as: Prescient Therapeutics, Ltd. | Virax Pty. Ltd,

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Sep 1, 2002

Last known activity

Mar 1, 2025

Timeline

1980s

Jan 1, 1987
Prescient Therapeutics, Ltd.— Founded

Drugs by trial phase (8 distinct, 7 trials)

Phase 2 (8 own, 0 via acquisition)

triciribine
carboplatin
triciribine
recombinant fowlpoxvirus expressing hiv gag-pol antigens
hiv gag-pol antigens
cytarabine
interferon gamma-1b
ptx-100

Indications

Studied for

Acute Disease
Carcinoma, Ovarian Epithelial
Leukemia
Neoplasm Metastasis
Neoplasms
Ovarian Neoplasms

Recent trials (7)

NCT06854653Lead sponsorPhase 2Mar 1, 2025
NCT03900442Lead sponsorPhase 1May 15, 2019
NCT02930109Lead sponsorPhase 1/Phase 2Sep 1, 2016
NCT01690468Lead sponsorPhase 1/Phase 2Sep 1, 2014
NCT00642031Lead sponsorPhase 1Aug 1, 2006
NCT00363454Lead sponsorPhase 1Apr 1, 2006
NCT00332930CollaboratorPhase 1/Phase 2Sep 1, 2002

Details

Founded: Melbourne, AU Jan 1, 1987
Last known activity: Mar 1, 2025

Notes

--- Pre-folding founded info: 1999-06-01 Melbourne AU https://www.crunchbase.com/organization/virax#section-overview --- --- Notes from Virax Pty. Ltd,: CRO ---